The 32% EV/EBITDA premium to Flowserve appears justified only if Crane's 18.6% operating margin proves durable, since Flowserve's 14.6% ROIC and 7.3% net margin suggest structurally lower earning power but also a materially cheaper entry point. The forward P/E of 27.43 versus 30.8x trailing implies consensus expects earnings to outgrow price, yet with management skipping guidance alongside the 10/27/2026 report, that implied growth trajectory is unanchored and investors should treat the PEG of 2.02 as a soft rather than firm signal. P/FCF of 32.64x versus P/E of 30.81x indicates the market is already paying more for cash than for accounting earnings, which warrants scrutiny given the -2.3% FCF margin in 2026Q3.

Gross margin of roughly 42% combined with a 18.4-19.9% operating margin band appears consistent with the designed-in, certification-protected profile of the A&E segment rather than with the more commoditized fluid handling exposure of peers, suggesting Crane converts revenue into profit at a structurally higher rate. However, operating margin ranging from 14.4% to 19.9% within 2026 alone, alongside net margin of 12.9% against 19.2% in 2025Q1, indicates that non-recurring items are materially influencing reported results. On that reading, the operating margin rather than the net margin is the more defensible proxy for underlying earning power, though even it should be adjusted for acquisition-related charges before being annualized.

Because ROE of 4.4% and ROA of 2.4% in 2026Q3 are also below their 2025Q1 peaks of 6.3% and 4.1% respectively, the pattern is consistent with capital being deployed faster than returns have had time to accrue, a common outcome shortly after a transformational deal. This matters more than usual for Crane because roughly one-third of the $4.0B asset base is goodwill, which sits in the invested-capital denominator but contributes no independent cash generation, so headline ROIC likely understates the return on the tangible operating assets. If returns do not inflect back toward the 4.8-5.5% range over the next several quarters, investors should consider whether the accretion thesis is being realized at the operating level rather than merely at the revenue line.

DSO improving to 61 days from 75 days in mid-2024 suggests customer collections have tightened, but the 105-111 day inventory holding period, last observed in 2026Q2, continues to dominate the cycle and reflects the long-lead, high-value nature of engineered aerospace and valve inventory rather than poor discipline. DPO near 43 days against that inventory float implies Crane funds most of its working capital itself, which is affordable at current coverage but means the CCC of roughly 107-140 days over the period has been a persistent, structural drag on cash conversion. DIO, DPO and CCC are unavailable for 2026Q3, so the most recent quarter's working capital posture cannot be assessed and should be monitored in the next disclosure.

The move from a de facto debt-free position to a 0.41 debt-to-equity ratio represents a genuine structural change in the credit profile, yet 10.26x coverage and a falling debt balance from the 2026Q1 peak suggest servicing remains comfortable by industrial standards. The reported D/EBITDA of 5.55x versus IDEX at comparable leverage and Flowserve's higher D/E of 0.78 appears inconsistent with Crane's low absolute debt load if annualized EBITDA were used, so the calculation basis warrants confirmation before it is used to assess refinancing risk. Note that the supplementary risk-factor analysis shows a debt-to-equity reading of 0.29 versus 0.41 in the snapshot, and that discrepancy should be resolved before the leverage profile is updated.